IMVT vs AMGN: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Amgen Inc in 2026
IMVT
Immunovant Inc
$26.55
AMGN
Amgen Inc
$350.95
Key Metrics Comparison
| Metric | IMVT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $5.11B | $188.58B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze IMVT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or AMGN a better investment?
Comparing IMVT and AMGN: Immunovant Inc has a market cap of $5.11B while Amgen Inc has $188.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and AMGN?
IMVT (Immunovant Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for IMVT.
Which company is more profitable: IMVT or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for IMVT.
Which is the larger company: IMVT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.58B compared to $5.11B for IMVT.
Should I buy IMVT or AMGN in 2026?
Both IMVT and AMGN have investment merit. IMVT trades at $26.55 while AMGN trades at $350.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and AMGN stock?
Key differences: Market Cap ($5.11B vs $188.58B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).